3E "Right to Try Act"; permitting the use of investigational drugs, biological products, or devices for certain eligible patients, providing exceptions; specifying medical assistance (MA) and early periodic screening, diagnosis, and treatment (EPSDT) programs does not cover costs for investigational drugs, biological products, or devices
(je)